IBB

IShares Nasdaq Biotechnology Index (ETF) (IBB): Short the Near-Term Action in the IBB ETF

Drug stocks have been hated by traders for more than a year, but that feeling is abating. Use long-term value to short IBB over the near term.

Biogen Inc (BIIB): Profit From the BIIB Stock Bears

Love it or hate it, the severe chop in Big Pharma presents opportunities to create income. Sell risk against value levels in Biogen (BIIB) stock.

Is Now the Time to Buy Into These 5 Biotech ETFs?

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

Illumina, Inc. (ILMN) Stock Is Nearing Breakout Territory

Illumina (ILMN) looks ripe for a break higher after ILMN stock spent the majority of the past two months in a sideways range.

Buy Bristol-Myers Squibb Co (BMY) Stock Without Fear

The consensus is that Trump will destroy the Biotech industry. I bet this will pass with little change, so go long BMY with room for error.

iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Crossroads

The iShares Nasdaq Biotechnology ETF (IBB) is showing relative strength, but the IBB ETF must overcome this hurdle to continue rallying.

Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock

The meme that biotechs are untouchable for as long as Trump is tweeting about price wars is ebbing. Go long IBB with room for error.

Catch Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free

Valeant Pharmaceuticals (VRX) has no shortage of haters, but don't be shy on red days. Go long VRX stock with a huge buffer zone!

Get in Biogen Inc (BIIB) Stock Before It Breaks Out

Biogen (BIIB) hasn't had much love from Wall Street this year, but its fundamentals are strong. Go long this popularity bottom in BIIB stock.

3 Healthcare Tickers That Will Return Profits in 3 Months

Not many experts dare fight Trump. Consequently, pharma stocks have been lidded. Try trades in GILD, BIIB and IBB while they are cheap.

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize

Valeant Pharmaceuticals (VRX) is finally getting its house in order. Don't expect VRX stock to explode, but it will get a lift.

iShares Nasdaq Biotechnology Index (ETF) (IBB) Shows Signs of Hope

The iShares Nasdaq Biotechnology ETF (IBB) gave off an initial signal of hope for a better rally in biotech stocks. Here's how to handle IBB.

Go Long Bristol-Myers Squibb Co (BMY) Stock for Panic Profits!

Pharmaceutical stocks like Bristol-Myers Squibb (BMY) have been toxic for months, but BMY stock is about to turn lemons into lemonade.

Buy Today’s Trump Dump in Biotech Stocks – XBI IBB

Biotech stocks and ETFs like iShares' IBB and SPDR's XBI were hammered Wednesday on Donald Trump's drug pricing comments. Opportunity knocks.

5 Stocks to Buy Ahead of the “January Effect”

Small caps with "tax loss selling" in December often make great buys in January. Here's a list of five potential opportunities for 2017.

Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits

Most traders look to hit home runs with Valeant Pharmaceuticals (VRX). I suggest simply settling for base hits on VRX stock.

Dow Jones Industrial Average Continues to Skyrocket

The Dow Jones Industrial Average may be overbought, but it seems like the markets are still pointed upward for now.

Amgen, Inc. (AMGN) Stock Might Be on Santa’s Buy List

Amgen (AMGN) just flashed a little encouragement to the bulls. While Amgen stock looks stuck, it very well could break out of its funk.

The 10 Best ETFs to Buy for 2017 and Beyond

Exchange-traded funds are a great way to position your portfolio for the new year. Here's 10 of the best ETFs for 2017's biggest trends.